findmyKOL
Clinical trialNCT05601063CompletedObservational

Ascertaining Diagnosis Classification With Elicited Speech

SponsorNorthwell HealthEnrollment255Anxiety DisordersAttention Deficit Hyperactivity DisorderBipolar and Related DisordersDepressive DisorderPersonality DisordersSchizophrenia Spectrum and Other Psychotic Disorders
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Sunny X Tang, MD

    Northwell Health, The Feinstein Institutes of Medical Research

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Zucker Hillside Hospital

    Glen Oaks, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Oct 2020
Primary completion
1 Sept 2022
Completion
1 Sept 2022
Last update posted
1 Nov 2022
Registered enrollment
255
Registry id
NCT05601063

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.